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Inﬂuenza hemagglutininechanisms of cell–cell fusion in development and diseases and, especially, about
fusion stages downstream of an opening of nascent fusion pore(s). Earlier works on different cell–cell fusion
reactions have indicated that cytoskeleton plays important role in syncytium formation. However, due to
complexity of these reactions and multifaceted contributions of cytoskeleton in cell physiology, it has
remained unclear whether cytoskeleton directly drives fusion pore expansion or affects preceding fusion
stages. Here we explore cellular reorganization associated with fusion pore expansion in syncytium
formation using relatively simple experimental system. Fusion between murine embryonic ﬁbroblasts
NIH3T3-based cells is initiated on demand by well-characterized fusogen inﬂuenza virus hemagglutinin. We
uncouple early fusion stages dependent on protein fusogens from subsequent fusion pore expansion stage
and establish that the transition from local fusion to syncytium requires metabolic activity of living cells.
Effective syncytium formation for cells with disorganized actin and microtubule cytoskeleton argues against
hypothesis that cytoskeleton drives fusion expansion.
Published by Elsevier B.V.1. IntroductionMembrane fusion is a critical event in biology. Exocytosis, protein
trafﬁcking, and entry of enveloped viruses involve membrane fusion
[1,2]. Moreover, fusion between cells plays key roles in development
as in sperm–oocyte fusion, trophoblast cell fusion, and the formation
of myotubes, osteoclasts, and giant cells [3,4]. Finally, fusion between
somatic cells and embryonic stem cells is an intriguing phenomenon
in physiology and an important tool in stem cell research [5].
Intracellular and intercellular fusion reactions have been exten-
sively studied in many experimental systems. The focus of this
research has been on identiﬁcation of the proteins involved and on the
mechanisms by which these proteins connect the membrane-
enclosed volumes with nascent nanometer-sized fusion pores. By
contrast, the extension of these pores and the cellular reorganization
that in the case of cell–cell fusion yield a syncytium have remained
poorly understood. Since cell shape and its changes are mainly
determined by the cytoskeleton, several studies have focused on its
role during syncytium formation, implicating either the actin or the
microtubule network [6–15]. However, even for the same experi-
mental system, fusion between Drosophilamyoblasts, the speciﬁc role
of the actin cytoskeleton: providing the driving force for fusion pore0 Center Drive, Bethesda, MD
2916.
mordik).
.V.extension [16], priming cells for fusion initiation [17], or restricting
membrane rearrangements [18], remains to be clariﬁed.
Due to the complexity of developmental cell fusion reactions and a
large number of proteins involved in controlling both pre- and post-
fusion stages, it is very hard to distinguish contributions of
cytoskeleton rearrangements during fusion pore expansion from
those at the preceding stages of cell–cell binding, plasma membrane
expression of yet unknown fusogens, their activation, and, ﬁnally,
fusion pore opening. In this work we address the fundamental
question whether cytoskeleton drives syncytium formation, using an
experimental system that is much simpler than cell fusion in
development. A robust and relatively fast fusion reaction between
mammalian cells is initiated here by a low pH-triggered restructuring
of one of the best-characterized protein fusogens inﬂuenza virus
hemagglutinin (HA).
The opening of initial fusion pores by low-pH forms of HA mimics
fusion between the viral envelope and the membrane of an acidiﬁed
endosome during virus entry. HA structure, its changes at the pH of
fusion, and the HA-mediated pathway that culminates in a fusion pore
opening have been studied in considerable detail [19–24]. Here, we
utilize HA to initiate fusion, but we concentrate on the transition from
early fusion pores to expanding cytoplasmic cell–cell connections
readily detectablewith ﬂuorescencemicroscopy.While the opening of
fusionpores requires only the presence of functionalHA, this transition
requires cell metabolic energy and is negatively regulated by protein
kinase C (PKC). Late and cell-dependent stages of fusion yielding
syncytium formation are not blocked by microtubule- and actin-
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actin cytoskeleton drives the enlargement of initial fusion connections.
2. Materials and methods
2.1. Reagents
Jasplakinolide and latrunculin A were purchased from Invitrogen.
Nocodazole, colchicine, taxol (paclitaxel), sodium azide (NaN3), 2-
deoxy-D-glucose, cytochalasin D, 2, 3-butanedione monoxime (BMD),
and blebbistatin were purchased from Sigma-Aldrich. Phorbol 12-
myristate 13-acetate (PMA), bisindolylmaleimide I, and staurosporine
were purchased from Calbiochem.
2.2. Cell culture and preparation
NIH 3T3 cells (murine embryonic ﬁbroblasts) and HAb2 cells (NIH
3T3 cells stably expressing HA [25]) were cultured as exponentially
growing subconﬂuent monolayers on 90-mm plates in DMEM
supplemented with Glutamax (Invitrogen) and 10% (v/v) fetal bovine
serum. Exponentially growing cells were dissociated with trypsin
(Invitrogen). The cells (2.5×105) were plated and cultured overnight
on 30-mm plates in the presence of 2.5 mM sodium butyrate to
potentiate expression of HA [26,27]. In some experiments, we used
human erythrocyte ghosts labeled with ﬂuorescent lipid PKH26
(Sigma, St. Louis, MO) and an aqueous dye, 6-carboxyﬂuorescein
(Invitrogen, Carlsbad, CA), prepared for experiments as described in
[22].
2.3. Fusion assay
To prepare them for fusion, HAb2 cells were pretreated with
trypsin (5 μg/ml, 5 min, 37 °C) to cleave the fusion-inactive precursor
of HA (HA0) to its fusion active (HAl-S-S-HA2) form [28]. The cells
were washed twice with PBS with Ca/Mg and exposed for 5 min to pH
4.9 medium at 37 °C, in order to trigger fusogenic conformational
change in HA. Cells were washed two more times with PBS and
incubated for 2 h in DMEM supplemented with serum. In the
experiments in which we combined low temperature incubation
with latrunculin treatment (Fig. 7B), trypsin pretreatment wasFig. 1. Low pH application results in a fast opening of a fusion pore followed by a much slow
tracker were treatedwith a 5-min low pH pulse. Then, starting immediately after re-neutraliz
cells (a hallmark of fusion pore formation), and gradual enlargement of intercellular connectio
2 dyes are already mixing, but each of the cells remains an individualized entity. The blue arr
adjacent fusing cells join in a big syncytium. The pictures were taken at t=5 min (A, A'); 25 m
bar, 50 μm.followed by additional 1-h incubation in PBS with Ca/Mg at 37 °C,
and then proceeded to fusion experiments.
2.4. Fluorescence microscopy
The different experiments were performed as described in the
ﬁgure legends. In the experiments with ﬁxed cells, Invitrogen's
protocol was used concerning the use of Alexa488-Phalloidin
(Invitrogen). Tubulin was labeled using mouse anti-alpha tubulin
antibody, with alexa594 donkey anti-mouse antibody as secondary
antibody (both Invitrogen). The distribution of ﬂuorescence was
analyzed on an Olympus IX70 inverted ﬂuorescence microscope.
2.5. Syncytium assay
Two hours after the end of the low-pH application, cells were
labeled with Hoechst (Invitrogen) and orange cell tracker (Invitrogen)
in order to better visualize their contour. Then, we analyzed ﬁve
random ﬁelds for each sample. The syncytium index for each sample
was determined as the number of nuclei in a multinucleated cell
divided by the total number of nuclei in the ﬁeld. To verify that the
formation of multinucleated cells involved cell fusion, in some
experiments (Fig. 1) we labeled half of the cells with green cell
tracker and half with orange (both cell trackers were purchased from
Invitrogen), mixed them, and grew the cells together overnight before
the trypsin/low-pH treatment. We scored cells as syncytia if they had
multiple nuclei in a single cell volume or if the connections between
fusing cells appeared to be large enough to allow nucleus passage.
Each graph is representative of data from one of three independent
experiments. For graphs that represent normalized data, at least three
independent experiments were performed.
3. Results
3.1. Experimental system
A number of earlier studies characterized HA-mediated fusion
between HAb2 cells and erythrocytes [26,29]. In this work to explore
the formation of multinucleate cells, we have focused on fusion
between HAb2 cells. These cells have the typical cytoskeleton ofer syncytium development. Co-plated cells pre-labeled with either orange or green cell
ation, we took pictures to follow redistribution of the probes between differently labeled
ns and changes in cell shapes. Thewhite arrows in A and E indicate a cell pair where the
ows mark the intercellular connection that expands from A to D and from A’ to D’when
in (B, B'); 45 min (C, C'); 105 min (D, D') after the beginning of low pH application. Scale
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(see below). Neighboring HAb2 cells contact each other through a
narrow motile lamellipodium sent from one cell to the body of
another cell. Pre-fusion contacts through lamellipodia are an
important feature of some biologically relevant fusion reactions,
such as the formation of multinucleate macrophages [30].
We always ﬁnd some background of binucleated cells, and rarely
also tri-nucleated cells, which likely represent dividing cells. As
expected, the numbers of these multinucleated cells do not change in
the control experiments with HAb2 cells not treated with low pH, or
treated with low pH without the trypsin pre-treatment that is
required for transforming HA into a fusion-competent form (not
shown). In contrast, a short-term treatment of a low-pH medium to
trypsin-treated HAb2 cells yields many multinucleated cells. These
cells are formed by fusion, since they contain both of the cell trackers
that initially are separated between different cell populations (Fig. 1).
Opening of fusion pores detected as redistribution of the probes and
thus appearance of double labeled cells is observed already at 5 min
after low pH application. However, the gradual enlargement of
intercellular connections and changes in cell shapes towards syncy-
tium formation develops much slower.
While we ﬁnd that HAb2 cells are capable of forming syncytia by
fusing with parental NIH 3T3 cells that do not express HA (data not
shown), all data presented below are obtained for fusion between
HAb2 cells. For these cells, 60 min after the end of low-pH application,
between 25% and 100% of all nuclei are in syncytia. The day-to-day
variability in the percentage of cells in syncytia after a low pH pulse
and in the number of multinucleated cells in our negative control
experiments (no low pH application) likely reﬂect the differences in
the state of cell cultures and the levels of HA expression. Therefore,
each of the presented sets of experiments includes its own negative
and positive controls.
Rapid and synchronized committing of many cells to fusion allows
us to focus on the unexplored late stages of syncytium formation.
3.2. Syncytium formation requires metabolic activity of living cells
Slowing down metabolism, either by lowering the cell-incubation
temperature to 4 °C or by depleting ATP pools by pre-treating cells
with NaN3 and 2-deoxy-D-glucose is often used to determine the
energy-dependency of a cellular process.Fig. 2. Syncytium formation proceeds only in metabolically active cells and is negatively reg
placed the cells at 4 °C immediately after the end of low pH pulse (A) or pre-treated them w
[59] (B). (A) In the control experiments cells were kept at 37 °C throughout experiment and
followed by a 2 h incubation at 4 °C and then scoring syncytia. For the cold-recovery experim
hours at 37 °C before monitoring of the syncytium index. (B) In the control experiments, the
(3) cells were preincubated in the ATP-depleting mix for 30 min prior to low pH applicatio
whether low pH-triggered syncytium formation involves protein kinases activities, im
bisindolylmaleimide I at a ﬁnal concentration of 500 nM (5), and staurosporine at a ﬁnal coNo syncytia are observed for cells chilled to 4 °C immediately after
a low-pH pulse. Even after 2 h of incubation at 4 °C, the bound cells
remain distinct rather than multinucleated (Fig. 2A). Raising the
temperature to 37 °C yields the same percentage of cells in syncytia as
that observed when the cells are incubated at 37 °C during the entire
experiment, suggesting that low temperature blocks only late fusion
stages. Similarly, in the experiments carried out entirely at 37 °C,
depletion of intracellular ATP pools of HAb2 cells by a combination of
NaN3 and 2-D-deoxyglucose completely inhibits syncytium formation
(Fig. 2B).
Neither ATP depletion nor incubation at 4 °C inhibits early fusion
stages. Prior to a low-pH application, we incubate the ATP-depleted
cells or the cells incubated at the cold temperature with a small
number of erythrocyte ghosts labeled with membrane and content
probes. After the low-pH application, we observe spreading of the
dyes from an erythrocyte (RBC) to the HAb2 cell that this RBC is bound
to. The dye spreads then to neighboring HAb2 cells that do not have
bound ﬂuorescent RBCs (Supplemental Figure S1). This strategy allows
us during experiments to deliver dyes to one of the fusing HAb2 cells
and then to monitor spreading of dyes between fusing HAb2 cells.
Cell-to-cell transfer of ﬂuorescent probes in the absence of a
syncytium indicates that ATP depletion blocks cell fusion downstream
of the opening of the initial fusion pores.
The conclusion that syncytium formation is not spontaneous but
rather involves cell machinery is further substantiated by experiments
with reagents modifying activity of protein kinase C (PKC), a key
regulator of cell physiology (Fig. 2C). PMA, a promoter of PKC, and
bisindolylmaleimide I and staurosporine, PKC inhibitors [31], respec-
tively inhibits and promote cell–cell fusion, suggesting that syncytium
formation is negatively regulated by PKC. We cannot at present
identify the mechanism involved, since PKC directly or indirectly
regulates quite a few of the important biochemical pathways [32].
To summarize, in contrast to early fusion stages, syncytium
formation proceeds only in metabolically active cells. This ﬁnding is
in agreement with earlier studies on syncytium formation induced by
different viral fusogens or by electroporation [6,33,34].
3.3. Microtubules in syncytium formation
To explore rearrangements of the microtubular network during
fusion between HAb2 cells, we ﬁx the cells at different times after theulated by PKC. A, B. To test whether cell–cell fusion is an energy dependent process, we
ith an ATP-depleting mix of sodium azide (5 mM) and 2-D-deoxyglucose (5 mM) in PBS
either treated (2) or not treated (1) with low pH. (3) Low pH pulse applied at 37 °C was
ents, cells were kept at 4 °C for 1 (4) or 2 h (5), and then were incubated for two more
cells that were not ATP-depleted were either treated (2) or not treated (1) with low pH.
n and kept under ATP-depleting conditions throughout the experiment. (C) To explore
mediately after re-neutralization we applied PKC-modifying reagents PMA (2–4):
ncentration of 20 nM (6). (1) Control with no reagents applied. All bars are mean+S.E.
Fig. 3. Syncytium formation is accompanied by restructuring ofmicrotubule network and loss and relocation ofMTOC. To explore the changes in the structure ofmicrotubule skeleton
during cell–cell fusion, the fusing cells were ﬁxed at different times after low pH application. Microtubules were labeled in red with mouse anti-alpha tubulin antibody (with
alexa594 donkey anti-mouse antibody as secondary antibody) and nuclei were labeled in blue with Hoechst. (A, A') the negative control without low pH application. (B–D and B'–D')
Images were taken at t=5 min (B, B'); 10 min (C, C'); and 125 min (D, D') after the beginning of low pH application. For each pair of images, the second image (images A'–D') includes
the superimposition of the nuclei, which helps in distinguishing single andmultinucleated cells, and clarifying the position of the nuclei in the syncytia, but can hide the MTOC. Scale
bar, 25 μm.
Fig. 4. Syncytium formation is unaffected by microtubule-modifying reagents.
Nocodazole (A) and taxol (B) were used at ﬁnal concentrations of 20 μM and 50 μM,
respectively, with a preincubation time of 1 h followed by a low pH application. After 2
more hours in the presence of the reagent, syncytium formation was scored. In the
control experiments, untreated cells were either exposed (A2, B1) or not exposed (A1)
to low pH medium. All bars are mean+S.E.
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with ﬂuorescent antibodies (Fig. 3). In untreated cells, we observe, as
expected, distinct microtubule bundles originating frommicrotubules
organizing center (MTOC) in the vicinity of nuclei. As soon as 5 min
after low pH application, microtubules labeling in fusing cells becomes
more diffused. Fusion between HAb2 cells results thus in a
rearrangement of the whole structure and shape of the microtubule
cytoskeleton. We observe no bundles of microtubules passing through
the expanding fusion pores. Even 2 h after the low-pH application,
when syncytium formation and the microtubule rearrangements
appear to be completed, we observe multinucleated cells containing
multiple microtubules organizing centers (MTOC) located away from
the gathered nuclei.
To test whether the microtubular network plays a functional
role in syncytium formation, HAb2 cells were pre-treated with the
microtubule-stabilizing agent taxol or with the microtubule-
destabilizing agent nocodazole (Fig. 4). As expected, these drugs
cause major disorganization of the microtubule network of the cells
(Supplemental Figure S2A–C). However, syncytium formation is inhi-
bited neither by taxol (Fig. 4A) nor by nocodazole (Fig. 4B). Interestingly,
nocodazole does not prevent the gatheringof nuclei in syncytia (Supple-
mental Figure S2B). Colchicine, another microtubule-destabilizing
agent, also does not inhibit syncytium formation (not shown).
Since disturbing the normal function and structure of the micro-
tubular network doesnot block syncytium formation forHAb2cells,we
conclude that microtubules andmicrotubule-dependent vesicle trans-
port do not play a major role in the expansion of fusion pores.
3.4. Actin-cytoskeleton rearrangements during syncytium formation
Many important properties of cell membranes are controlled by
their interactions with the actin cytoskeleton and, especially, with the
actin-based contractile cortex under the plasma membrane. The actin
cytoskeleton might generate force through myosin-dependent con-
traction or actin polymerization [35], and it has been hypothesizedthat fusion pores are expanded by actin bundles assembled at the arc-
shaped edges of the pores [36].
Preparation of HAb2 cells for fusion includes incubation with
trypsin. We ﬁnd trypsin application to cause a very fast disassembly of
the actin cortex and internal stress ﬁbers (Fig. 5). This disassembly
might involve activation of protease receptors on the cell surface
described in [37]. Thus, at the time of fusion-triggering low-pH
application, the actin cytoskeleton is very much disorganized. Fifteen
minutes after the end of the low-pH pulse, the actin cytoskeleton
structures visibly recover and reorganize to ﬁt the shape of the newly
formed entity. We never observe actin stress ﬁbers invading the
expanding lumen connecting two fusing cells. Two hours after the
Fig. 5. Reorganization of initially disassembled actin cytoskeleton during syncytium formation. Time-lapse experiments follow changes in actin cytoskeleton after its initial
dissociation caused by trypsin pretreatment, through low pH-induced cell–cell fusion. At different times after low pH application the cells were ﬁxed and labeled with Alexa488-
Phalloidin and nuclei were labeled in blue with Hoechst. (A) is the control with non treated cells. (B) shows cells at the end of low pH application. Fig. 5(C–E) and (F) 5, 15, 60, 120 min
after the end of low pH application. Scale bar, 20 μm.
454 J.-P. Richard et al. / Biochimica et Biophysica Acta 1788 (2009) 450–457low-pH pulse application, strong cortical actin staining and stress
ﬁbers can be detected in all multinucleated cells.
In brief, we observe no accumulation of actin cytoskeleton inside
or underneath the fusion pores, arguing against a role of actin bundles
assembled at the edges of the fusion pores suggested in [36].
3.5. Effects of actin-modifying treatments
To further explore the possible involvement of the actin
cytoskeleton in syncytium formation, we disturb actin structuresFig. 6. Disturbance of actin structures with jasplakinolide, latrunculin, and cytochalasin D do
cytochalasin D (panel D) were used respectively at ﬁnal concentrations of 2 μM, 3 μM, and 5 μ
the presence of the reagents until scoring syncytia. (Panel A) shows the positive control, wher
presence of actin-modifying agents. Scale bar, 50 μm.in HAb2 cells with actin depolymerizing (cytochalasin D and
latrunculin A) or actin polymerizing (jasplakinolide) reagents [38].
Note that jasplakinolide under our conditions is also expected to
disorder the actin cytoskeleton [39]. The concentrations of actin-
modifying reagents in these experiments are within the ranges
recommended by Invitrogen protocols and used in earlier studies
([40] and [39], [41], [42] and [7]. While neither of these reagents
prevents HA-initiated syncytium formation (Fig. 6), quantitative
comparison of syncytium formation with or without these treat-
ments is hindered by the agent-induced changes in cell shapes (cellses not block syncytium formation. Latrunculin A (panel B), jasplakinolide (panel C), and
Mwith a preincubation time of 30 min. After low pH application, the cells were kept in
e the syncytium totally covered the ﬁeld observed. (B–D) Syncytia are still formed in the
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fusion stages.
In another experimental approach, we pre-incubate HAb2 cells at
4 °C for 1 h prior to the application of low pH (Fig. 7A). This pre-
treatment leads to a profound disassembly of the actin cytoskeleton
(as conﬁrmed by labeling of ﬁxed cells with ﬂuorescent phalloidin,
Supplemental ﬁgure S3), with no apparent change in cell–cell
contacts. Disorganization of actin structures at the time of low-pH
application does not inhibit syncytium formation. At the opposite, we
observe a small but reproducible promotion.
In the experimental design described above, fusion is initiated by
treating cells with warm (37 °C) acidic medium; and, thus, syncytium
formation develops at the time when the actin cytoskeleton starts to
recover. To verify that syncytium formation develops evenwhen such
recovery is blocked, we follow low-temperature-induced dissociation
of the actin cytoskeleton with application of latrunculin A, a strong
actin depolymerizing agent (Fig. 7B). HAb2 cells are treated with
trypsin for 5 min and incubated for 1 h in PBS at 37 °C with Ca/Mg in
order to recover actin cytoskeleton- and lamellipodium-mediated
contacts between the neighboring cells. Cells are then treated for 5min
with low pH at 37 °C to allow all cell pairs destined to fuse to have
nascent fusion pores already open [43]. The cells are then incubated at
4 °C for 1 h in order to disassemble the actin cytoskeleton, and, ﬁnally,
the temperature is raised to 37 °C in the presence or absence of
latrunculin A. The syncytium index is monitored 2 h after that.
In the control experiments, to evaluate the degree of recovery of
the actin cytoskeleton after raising the temperature, we ﬁx the cells at
different times (0, 5, 15, 30, 60, and 120 min) and label them with
Alexaﬂuor488-tagged phalloidin. While 15min at 37 °C in the absence
of latrunculin is sufﬁcient to completely restore the actin cytoskeleton,
we never observe actin structure recovery in the presence of
latrunculin (data not shown).
Thus, in the experimentswhere actin cortex has been dissociated at
the onset of fusion and remains dissociated throughout the fusion poreFig. 7. Depolymerization of actin (A, B) and myosin inhibitors (C) did not lower the
efﬁciency of syncytium formation. (A) To depolymerize actin structures, the cells were
preincubated for 1 h at 4 °C before low pH application at 37 °C (2). In the control
experiment (1) the low temperature pre-treatment was skipped. (B) A possible recovery
of actin structures after raising the temperature was prevented by following low
temperature treatment with latrunculin A application. After low pH application at 37 °C,
the cells were kept for 1 h at 4 °C in complete medium, then the medium was replaced
with a warm medium containing 2 μM latrunculin A (2) or, in the control experiment
(1), latrunculin-free medium. The cells were incubated for two more hours at 37 °C
before quantifying the syncytium formation. (C) Incubation of the cells with inhibitors
of non-muscle myosin II: blebbistatin at 100 μM (2) or butanedione monoxime, BMD at
10 mM (3), started 30 and 15min, prior to trypsin application and then kept throughout
the experiments, respectively, had no effect on syncytium formation, as compared with
that in the control experiment without inhibitors (1). All bars are mean+S.E.expansion, fusion yields efﬁcient syncytium formation (Fig. 7B). These
ﬁndings, along with the results in Fig. 7A, argue against the hypothesis
that actin cytoskeleton drives the expansion. On the contrary, as shown
in the experiments presented in Fig. 7A, we observe a slight increase in
the number of multinucleated cells suggesting that actin cytoskeleton,
if anything, restricts syncytium formation.
Generation of force by the actin cortex beneath the plasma
membranes might involve myosin-dependent contraction [44]. In
addition, properties of the actin cortex under the plasma membrane
might be modulated by myosin II-driven contraction [45]. To explore
whether syncytium formation depends onmyosin activity, we use two
inhibitors of non-muscle myosin II: blebbistatin and BMD (Fig. 7C)
[46–48]. Neither of these reagents has an effect on the efﬁciency of
syncytium formation.
To summarize, syncytium formation in cells with depolymerized
actin structures and inhibited active contraction proceeds with at least
the same efﬁciency as in control cells, arguing against hypothesis that
actin cytoskeleton drives the expansion of fusion pores.
4. Discussion
Cell–cell fusion plays an important role in development (for
instance, sperm–egg fusion and myotube formation), throughout our
lives (fusion of macrophages), and in pathophysiology (viral syncytia).
The mechanisms by which fusion pores generated by specialized
proteins expand to connect cells by a passage wide enough to allow
redistribution of cell nuclei are poorly understood. Our experimental
system of HA-initiated syncytium formation based on a well
characterized and easy to trigger fusogen provides a controlled way
of forming fusion pores and, thus, facilitates analysis of the mechan-
isms of their expansion. In contrast to many developmental cell–cell
fusion models, our system is based on mammalian cells in order to
minimize potential orthology problems [49,50]. Furthermore, while in
an important mammalian syncytium model of myoblast fusion the
multistep cascades of regulation only yield detectable syncytia at least
12 h after triggering [49,51], we can already speciﬁcally study cellular
reorganization downstream of fusion pores opening to yield syncytia
within 1 h after triggering.
We explore whether fusion pore extension yielding syncytia
requires any contribution of the cells or whether the opening of a
fusion pore detectable with light microscopy signiﬁes an irreversible
commitment to syncytium formation (with subsequent stages to
proceed spontaneously). Finding that metabolic inhibitors such as low
temperature or ATP depletion block transition from early fusion
intermediates to formed syncytia suggests that syncytium formation
is controlled by cell machinery. In the experiments in which fusion is
blocked by lowering of the temperature to 4 °C immediately after
fusion pore opening, lifting the block 1 h later by raising the
temperature to 37 °C fully restores the syncytium index. This ﬁnding
suggests that the small pore(s) in between the two fusing cells remain
(s) open and are just waiting for the cells to continue the syncytium
formation process by providing sufﬁcient energy for the internal
rearrangements to occur. The importance of the cell machinery in
syncytium formation is further emphasized by studying the effects of
reagents modifying PKC activity. PKC is central to many regulatory
pathways in cells, including the regulation of actin reorganization
[52,53] and of cell machinery involved in membrane trafﬁcking [54].
Speciﬁc mechanisms of negative regulation of syncytium formation by
PKC and PKC isoforms involved remain to be clariﬁed. However, the
fact of cell fusion dependence on PKC activity strengthens the
conclusion that after protein fusogens have carried out their job of
opening fusion pores, the subsequent fusion stages are controlled by
cell physiology.
Early studies on electrofusion [6] and a more recent work on
myoblast formation [55] suggested that microtubule dynamics and
microtubule-associated proteins play an important role in syncytium
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intracellular compartments. Microtubules interact with the Golgi
apparatus, the endoplasmic reticulum, and also endo- and exocytotic
vesicles. It has been proposed that microtubules invade the cytoplas-
mic bridge between the fusing cells, connect the two nuclei and drive
pore expansion and the subsequent cellular reorganization [6].
However, our data with drugs over-stabilizing or destroying micro-
tubules argue against this hypothesis and indicate that the micro-
tubule cytoskeleton is not necessary for syncytium formation to
proceed. Moreover, we never observe a signiﬁcant strengthening of
microtubular network in syncytium formation during time-lapse
experiments with ﬁxed cells. Interestingly, the microtubule cytoske-
leton, after 2 h of incubation in DMEM supplemented with serum at
37 °C, seems fully restored despite MTOC misplacement.
In our system, microtubule-modifying drugs have no effect on the
circular nucleus gathering after cell fusion, as presented in Supple-
mental Figure S4. The mechanisms that underlie this gathering are yet
unclear. Nucleus movement in cells has been proposed to be driven by
either microtubule- or actin-cytoskeleton [15,56,57], and our ﬁndings
indicate that functional microtubular network is not a prerequisite for
the nuclei gathering. In addition, we never observe fusion between
nuclei in any experiment, each of them keeping its own individuality
after fusion.
Cell shape is highly dependent on the actin cytoskeleton, as the
plasma membrane lies on a cortical actin meshwork [58]. The actin
cytoskeleton supports transformations in cell shape such as mem-
brane bending into lamellipodia, ﬁlopodia, or simply microspikes.
Here, we explore the role of the actin cytoskeleton in syncytium
formation. Our ﬁnding that actin-modifying reagents and treatments
as well as myosin inhibitors do not inhibit HA-initiated syncytium
formation argue against the hypothesis that enlargement of the
cytoplasmic connection between fusing cells is driven by actin
structure [16]. Moreover, a slight increase in syncytium formation
for the cells with depolymerized actin cytoskeletons (Fig. 7A and B)
suggests that actin structures restrain cellular reorganization into
syncytia. Interestingly, dissociation of the cytoskeleton has been
reported to facilitate several membrane remodeling processes.
Disruption of membrane skeleton of erythrocytes is found to promote
HA-mediated fusion between viral particles and erythrocytes [59].
Experiments with locally applied actin-modifying agents demonstrate
that actin depolymerization along the cleavage furrow is important for
furrow ingression during cytokinesis [60]. Local disassembly of the
actin cortex also plays an important role in exocytosis, allowing
intracellular vesicles to fuse with the plasma membrane [61].
In conclusion, we have proved that transition from early HA-
initiated fusion stages to syncytium formation is an active process
requiring energy provided by the cell machinery and is dependent on
PKC regulation signaling cascades. Efﬁcient syncytium formation
observed for the cells treated with reagents that modify microtubule
and actin structures argues against the hypothesis that the late stages
of cell–cell fusion are driven by cytoskeleton. The dependence of late
fusion stages on metabolic activity of living cells and syncytium
formation for cells with depolymerized actin skeleton have been also
observed for fusion initiated by baculovirus gp64, another protein
fusogen [62].
The mechanistic insights provided by our simpliﬁed experimental
model based on well characterized viral fusogens will hopefully help
in elucidation of complex cell–cell fusion reactions in development
and pathophysiology.
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